A

Apellis Pharmaceuticals
D

APLS

30.390
USD
0.29
(0.96%)
Market Closed
Volume
45,120
EPS
-1
Div Yield
-
P/E
-15
Market Cap
3,780,303,787
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.02000
    (0.63%)
    3.22000 USD
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    A
    ANAB
    -0.750
    (-4.44%)
    16.130 USD
    A
    ARWR
    -0.050
    (-0.25%)
    19.710 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    BMY
    BMY
    0.025
    (0.04%)
    57.075 USD
    C
    CRBP
    -0.620
    (-5.18%)
    11.350 USD
    E
    EXEL
    -3.560
    (-9.77%)
    32.880 USD
    GE
    GE
    0.700
    (0.37%)
    188.300 USD
    GSK
    GSK
    -0.340
    (-1.01%)
    33.440 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    More
News

Title: Apellis Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.